P21556
Gene name |
PTAFR |
Protein name |
Platelet-activating factor receptor |
Names |
PAF-R, PAFr |
Species |
Cavia porcellus (Guinea pig) |
KEGG Pathway |
cpoc:100720710 |
EC number |
|
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for P21556
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-P21556-F1 | Predicted | AlphaFoldDB |
No variants for P21556
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| No variants for P21556 | |||||
No associated diseases with P21556
1 regional properties for P21556
| Type | Name | Position | InterPro Accession |
|---|---|---|---|
| domain | GPCR, rhodopsin-like, 7TM | 32 - 293 | IPR017452 |
2 GO annotations of cellular component
| Name | Definition |
|---|---|
| integral component of membrane | The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. |
| plasma membrane | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
4 GO annotations of molecular function
| Name | Definition |
|---|---|
| lipopolysaccharide binding | Binding to a lipopolysaccharide. |
| lipopolysaccharide immune receptor activity | Combining with a lipopolysaccharide and transmitting the signal across the cell membrane to initiate an innate immune response. Lipopolysaccharides (LPS) are major components of the outer membrane of Gram-negative bacteria, making them prime targets for recognition by the immune system. |
| phospholipid binding | Binding to a phospholipid, a class of lipids containing phosphoric acid as a mono- or diester. |
| platelet activating factor receptor activity | Combining with platelet activating factor to initiate a change in cell activity. |
4 GO annotations of biological process
| Name | Definition |
|---|---|
| chemotaxis | The directed movement of a motile cell or organism, or the directed growth of a cell guided by a specific chemical concentration gradient. Movement may be towards a higher concentration (positive chemotaxis) or towards a lower concentration (negative chemotaxis). |
| inflammatory response | The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages. |
| inositol trisphosphate biosynthetic process | The chemical reactions and pathways resulting in the formation of inositol trisphosphate, 1,2,3,4,5,6-cyclohexanehexol, with three phosphate groups attached. |
| phosphatidylinositol-mediated signaling | The series of molecular signals in which a cell uses a phosphatidylinositol-mediated signaling to convert a signal into a response. Phosphatidylinositols include phosphatidylinositol (PtdIns) and its phosphorylated derivatives. |
No homologous proteins in AiPD
| UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
|---|---|---|---|---|
| No homologous proteins | ||||
| 10 | 20 | 30 | 40 | 50 | 60 |
| MELNSSSRVD | SEFRYTLFPI | VYSIIFVLGI | IANGYVLWVF | ARLYPSKKLN | EIKIFMVNLT |
| 70 | 80 | 90 | 100 | 110 | 120 |
| VADLLFLITL | PLWIVYYSNQ | GNWFLPKFLC | NLAGCLFFIN | TYCSVAFLGV | ITYNRFQAVK |
| 130 | 140 | 150 | 160 | 170 | 180 |
| YPIKTAQATT | RKRGIALSLV | IWVAIVAAAS | YFLVMDSTNV | VSNKAGSGNI | TRCFEHYEKG |
| 190 | 200 | 210 | 220 | 230 | 240 |
| SKPVLIIHIC | IVLGFFIVFL | LILFCNLVII | HTLLRQPVKQ | QRNAEVRRRA | LWMVCTVLAV |
| 250 | 260 | 270 | 280 | 290 | 300 |
| FVICFVPHHM | VQLPWTLAEL | GMWPSSNHQA | INDAHQVTLC | LLSTNCVLDP | VIYCFLTKKF |
| 310 | 320 | 330 | 340 | ||
| RKHLSEKLNI | MRSSQKCSRV | TTDTGTEMAI | PINHTPVNPI | KN |